openPR Logo
Press release

North America Peptide Based Hematological Disorders Therapeutics Market to Reach Value of US$ 220 Mn by 2022 end

04-08-2021 03:52 AM CET | Health & Medicine

Press release from: Fact.MR

Peptide based haematological disorders therapeutics market is exhibiting robust growth. This is due to the fact that technology for the manufacturing of peptides is rapidly evolving, with manufacturers and suppliers exploring new methods for the manufacturing of peptides. This has a positive effect on the peptide therapeutics market and leads to the formation of longer and complex chain of peptides and reduced cost of production.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=189

In addition, due to the emergence of automated instruments, there have been improvements in the purification process of peptides and reduction in the total waste generated. These are the factors driving the growth of the peptide therapeutics market worldwide. On the other hand, the synthesis and the purification of long peptides is difficult for manufacturers. In addition, the rise in modifications and the addition of more number of unnatural amino acids have made the process of peptide synthesis complex.

This makes the manufacturing of peptides difficult, and hence the gap between demand and supply is increasing and the cost of manufacturing of peptides is also accelerating, thereby hampering market growth.

The global peptide based hematological disorders therapeutics market is slated to touch a value of nearly US$ 530 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=189

4 Forecast Highlights on Global Peptide Based Hematological Disorders Therapeutics Market

1. As per the forecast of Fact.MR, the ecallantide segment is slated to touch a value of nearly US$ 120 Mn in the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The ecallantide segment is estimated to account for more than one-fifth of the revenue share of the drug segment by the year 2017 end and is expected to gain in market share by the year 2022 end.
2. As per the forecast of Fact.MR, the retail pharmacies segment will reach a value of nearly US$ 115 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The retail pharmacies segment is estimated to account for more than one-third of the revenue share of the distribution channel segment in the year 2017 end and is expected to gain market share by the end of the year 2022.
3. As per the forecast of Fact.MR, by the end of 2022, North America peptide based hematological disorders therapeutics market is projected to reach nearly US$ 220 Mn, registering a robust CAGR over the forecast period.
4. As perFact.MR forecasts, the US peptide based hematological disorders therapeutics market is estimated to account for 88.6% revenue share of the global peptide based hematological disorders therapeutics market by 2017 end and is expected to gain in market share by 2022 over 2017.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/189/S

The report has also profiled leading players in the global market for peptide based hematological disorders therapeutics, which will remain active through 2022. These include companies such as Shire plc.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/189/peptide-based-hematological-disorders-therapeutics-market
Content Source: https://www.factmr.com/media-release/179/peptide-based-hematological-disorders-therapeutics-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America Peptide Based Hematological Disorders Therapeutics Market to Reach Value of US$ 220 Mn by 2022 end here

News-ID: 2267467 • Views: 135

More Releases from Fact.MR

Adhesion promoters market: business opportunities, current trends, challenges & …
Adhesion Promoters Market: Overview and Dynamics Adhesion promoters are widely used in the development and manufacture of numerous products. It covers the layer of material or the skin of material to enhance the adhesion capabilities of an adhesion promoter. Regarding the efficacy of the end application of adhesion products in a variety of paint, coating, and plastic applications, the physical state of the interface is a major solicitation factor. The market for
5-hydroxytryptophan market near term outlook to remain stunted owing to covid-19 …
5-Hydroxytryptophan Market: Overview and Dynamics The important amino acid precursor used in serotonin formulations is 5-hydroxytryptophan. It is also known as the neurotransmitter precursor of the melatonin hormone. It serves as a booster for serotonin synthesis. With the changing lifestyle of people, stiffness in people’s lives is increasing this is booming the demand for 5-hydroxytryptophan. In comparison to Tryptophan, 5-hydroxytryptophan can easily cross the blood-brain barrier that makes it easy to
Plant-based Fish Market worth US$ 1.3 Billion by 2031 - Exclusive Report by Fact …
As environmental concerns associated with meat and seafood consumption heighten, consumers are turning towards more nature-friendly alternatives, prompting a slew of start-up companies to offer a broad range of plant-based product offerings. Sales of plant-based food products have witnessed unprecedented gains in recent years, with the global food & beverage market experiencing extensive marketing and promotion campaigns for the same. According to the U.S. Department of Agriculture, the average quantity of
04-10-2021 | Health & Medicine
Fact.MR
Europe to Take Large Share in Global Telestroke Services Market, While North Ame …
Telestroke services is a sub-category of telemedicine, which is often used for medical consultations in rural areas that facilitate care of patients with acute stroke at underserviced hospitals. The telestroke service’s benefit is expected to give appraisal, administration, analysis, and demeanor basic leadership administrations to patients with intense stroke. The Various type of telestroke services provided to acute stroke patients, Videoconferencing technologies play an imperative role in telestroke services that

All 5 Releases


More Releases for CAGR

Catalase Market : Research Observes Strong CAGR Development
The "Global Catalase Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024", report intends to offer a resourceful means to assess the Catalase Market and entails the all-inclusive analysis and upfront statistics with regards to the market. This new report is committed fulfilling the requirements of the clients by giving them thorough insights into the market. The Catalase Market report, titled Catalase Market, is expansive research
Citicoline Market | CAGR of 14.4%
The global Citicoline Market 2020 Report provides fine intelligence that helps market players to compete well against the tough competition on the basis of growth, sales and other various important factors. The research report lays stress on key growth opportunities and market trends apart from important market dynamics including market drivers and challenges. With the help of this report, involved parties can equip themselves to adapt along with the changes
Footwear Market : Research Observes Strong CAGR Development
The "Global Footwear Market Set for Rapid Growth, to Reach Around USD 320.44 Billion by 2023", report intends to offer a resourceful means to assess the Footwear Market and entails the all-inclusive analysis and upfront statistics with regards to the market. This new report is committed fulfilling the requirements of the clients by giving them thorough insights into the market. The Footwear Market report, titled Footwear Market, is expansive research
Xanthates Market CAGR to Grow at 4.7%
Persistence Market Research in its latest report projects that the global xanthates market will grow at a CAGR of 6.1% over the forecast period (2017-2025). Owing to Xanthates’ excellent mineral ore processing capabilities, its global sales have witnessed a significant rise in recent years. Mining complexity and declining ore quality have led to a major increase in demand for specialty chemicals to process ores. Towards the end of 2025, around
Global Serious Games Market Show 19.2% CAGR
A new report added by Allied Market Research, forecast that the global serious games market was valued at $2,731 million in 2016, and is projected to reach $9,167 million by 2023, growing at a CAGR of 19.2% from 2017 to 2023. The consumers segment is anticipated to grow at the highest rate during the forecast period. Asia-Pacific generated the highest revenue in the global serious games market in 2016 due to
Bioinsecticides market expecting CAGR 5.4%
Reports And Markets Publish a New Market Research Report On –"Bioinsecticides market- Growth, Trends, Forecast for the period (2017 - 2022)" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/1071910-global-bioinsecticides-market-growth-trends-forecast-for-the-period-2017-2022 Pesticides constitute the largest category within the market for crop protection chemicals, with biopesticides accounting for a comparatively minute share. Global consumption of synthetic insecticides is projected to reach 833.32 thousand tons by volume and USD 19.6 billion by value by 2020